New Parkinson's gel aims to smooth out daily life
NCT ID NCT07313176
Summary
This study is observing how well a gel medication called LECIGON® works for people with advanced Parkinson's disease over one year. It involves 215 adults who were previously treated with a different injected medication. The main goal is to see if the gel reduces the amount of daily 'off' time when Parkinson's symptoms return, and to check its impact on quality of life and sleep.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Complejo Hospitalario Universitario de A Coruña (CHUAC)
RECRUITINGA Coruña, 15006, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virgen del Rocío University Hospital
RECRUITINGSeville, Av. Manuel Siurot, S/n, 41013, Spain
Contact
Conditions
Explore the condition pages connected to this study.